BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10087054)

  • 21. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study.
    Curran EJ; Watson SJ
    J Comp Neurol; 1995 Oct; 361(1):57-76. PubMed ID: 8550882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.
    Ridray S; Griffon N; Mignon V; Souil E; Carboni S; Diaz J; Schwartz JC; Sokoloff P
    Eur J Neurosci; 1998 May; 10(5):1676-86. PubMed ID: 9751140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
    Booze RM; Wallace DR
    Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active versus passive cocaine administration: differences in the neuroadaptive changes in the brain dopaminergic system.
    Stefański R; Ziółkowska B; Kuśmider M; Mierzejewski P; Wyszogrodzka E; Kołomańska P; Dziedzicka-Wasylewska M; Przewłocki R; Kostowski W
    Brain Res; 2007 Jul; 1157():1-10. PubMed ID: 17544385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors.
    Hunter RG; Jones D; Vicentic A; Hue G; Rye D; Kuhar MJ
    Neuropharmacology; 2006 Jun; 50(7):858-64. PubMed ID: 16458333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons.
    Gurevich EV; Joyce JN
    Neuropsychopharmacology; 1999 Jan; 20(1):60-80. PubMed ID: 9885786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal phencyclidine treatment selectively attenuates mesolimbic dopamine function in adult rats as revealed by methamphetamine-induced behavior and c-fos mRNA expression in the brain.
    Semba J; Tanaka N; Wakuta M; Suhara T
    Synapse; 2001 Apr; 40(1):11-8. PubMed ID: 11170217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period.
    Berrendero F; Sepe N; Ramos JA; Di Marzo V; Fernández-Ruiz JJ
    Synapse; 1999 Sep; 33(3):181-91. PubMed ID: 10420166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D3 and D2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures.
    Larson ER; Ariano MA
    Synapse; 1995 Aug; 20(4):325-37. PubMed ID: 7482292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing dopamine D3-receptors in the nucleus accumbens shell in vivo induces changes in cocaine-induced hyperlocomotion.
    Bahi A; Boyer F; Bussard G; Dreyer JL
    Eur J Neurosci; 2005 Jun; 21(12):3415-26. PubMed ID: 16026479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors.
    Le Moine C; Bloch B
    Neuroscience; 1996 Jul; 73(1):131-43. PubMed ID: 8783237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography.
    Landwehrmeyer B; Mengod G; Palacios JM
    Eur J Neurosci; 1993 Feb; 5(2):145-53. PubMed ID: 8261096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of repeated treatment with mirtazapine on the central dopaminergic D2/D3 receptors.
    Rogóz Z; Wróbel A; Dlaboga D; Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2002; 54(4):381-9. PubMed ID: 12523492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of striatal dopamine receptors by estrogen.
    Lammers CH; D'Souza U; Qin ZH; Lee SH; Yajima S; Mouradian MM
    Synapse; 1999 Dec; 34(3):222-7. PubMed ID: 10523759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity.
    Harrison LM; LaHoste GJ
    Neuroscience; 2006; 137(2):483-92. PubMed ID: 16352400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction patterns of transcription factors of the nur family (nurr1, nur77, and nor-1) by typical and atypical antipsychotics in the mouse brain: implication for their mechanism of action.
    Maheux J; Ethier I; Rouillard C; Lévesque D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):460-73. PubMed ID: 15615863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A neural substrate of hyperactivity in borna disease: changes in brain dopamine receptors.
    Solbrig MV; Koob GF; Joyce JN; Lipkin WI
    Virology; 1996 Aug; 222(2):332-8. PubMed ID: 8806517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex.
    Maple AM; Perna MK; Parlaman JP; Stanwood GD; Brown RW
    Eur J Neurosci; 2007 Nov; 26(9):2532-8. PubMed ID: 17970732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
    Piercey MF; Walker EL; Feldpausch DL; Camacho-Ochoa M
    Neurosci Lett; 1996 Nov; 219(2):138-40. PubMed ID: 8971799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons.
    Tronci E; Simola N; Carta AR; De Luca MA; Morelli M
    J Neurochem; 2006 Aug; 98(4):1078-89. PubMed ID: 16771831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.